
|Videos|May 18, 2017
Biosimilars Continue Trending Upward
Author(s)Lauren Santye, Assistant Editor
Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.
Advertisement
Jonathan Van Lare, PharmD, director of Pharmacy Advantage, discusses the growth of biosimilars in specialty pharmacy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First OTC Acetaminophen–Naproxen Combination for 12-Hour Pain Relief
2
Thoracic Radiotherapy Added to Atezolizumab Raises Fatal Toxicity Risk in ES-SCLC
3
Two Weeks In: What the Medicare GLP-1 Bridge Actually Looks Like at the Counter
4
How Is VER-01 Different From Medical Cannabis?
5










































































































